	US 12,247,054 B2
	Curcumin-peptide conjugates and formulations thereof
Adam J. Payne, Oklahoma City, OK (US); Michael Centola, Oklahoma City, OK (US); and John Chancey, Edmond, OK (US)
Assigned to Haus Bioceuticals, Inc.; and John Chancey
Filed by Haus Bioceuticals, Inc., Oklahoma City, OK (US); and John Chancey, Edmond, OK (US)
Filed on Sep. 1, 2020, as Appl. No. 17/008,912.
Application 17/008,912 is a division of application No. 14/710,578, filed on May 12, 2015, granted, now 10,968,260.
Claims priority of provisional application 61/992,123, filed on May 12, 2014.
Prior Publication US 2020/0399331 A1, Dec. 24, 2020
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 36/00 (2006.01); A61K 31/12 (2006.01); A61K 47/54 (2017.01); A61K 47/64 (2017.01); C07K 14/47 (2006.01); C07K 14/76 (2006.01)

CPC C07K 14/47 (2013.01) [A61K 31/12 (2013.01); A61K 47/542 (2017.08); A61K 47/64 (2017.08); C07K 14/4717 (2013.01); C07K 14/76 (2013.01)]

4 Claims

1. A composition comprising a curcumin conjugated to a rice protein to form a curcuminoid-rice protein complex with a curcumin to rice protein ratio of is 1:1 (mg:g), or 1:≤10 (mg:g), or 10:≥1 (mg:g), or 25:1 (mg:g), or 1:50 (mg:g).